FDA Alerts Of Fake Botox Linked To Illnesses, Hospitalizations

April 18, 2024

FDA is alerting health care professionals and consumers that unsafe counterfeit versions of Botox (botulinum toxin) have been found in multiple states and administered to consumers for cosmetic purposes.

The U.S. Food and Drug Administration (FDA) in an alert released on Tuesday. This comes after the Centers for Disease Control and Prevention (CDC) announced an investigation into reported illnesses in at least 19 women after they recieved Botox injections “from unlicensed or untrained individuals or in non-healthcare settings, such as homes and spas.”

Why It Matters: Counterfeit or mishandled botox in at least nine states has resulted in 19 women suffering from symptoms including vision problems and trouble swallowing and breathing; nine of the women were hospitalized. The fake botox products appear to have come from unlicensed sources, and “may be misbranded, adulterated, counterfeit, contaminated, improperly stored and transported, ineffective and/or unsafe,” according to the FDA.

The FDA notes that if people have received botox and are experiencing symptoms such as dry mouth or difficulty swallowing, to “contact a health care professional or go to the emergency room.” If consumers are considering receiving botox, the FDA and CDC advise to confirm the injection is FDA approved and from an authorized source and to ask if the provider is licensed and trained to give the injection.

Read More: Counterfeit Version of Botox Found in Multiple States (FDA)

Fake Botox is the cause of bad reactions in 9 states, FDA says (NBC News)

Counterfeit Botox found in multiple states linked to hospitalizations (The Washington Post)

by Emily Hooker, based in Texas